BAROSTIM® Hope for Heart Failure Study

Status unconfirmed · Not applicable

Conditions studied: Heart Failure

In brief

The purpose of this clinical investigation is to assess the long-term safety and efficacy of the BAROSTIM NEO System in subjects currently participating in the BAROSTIM® HOPE4HF Trial (NCT01720160).

Key facts

Study ID

NCT01720160

Run by

CVRx, Inc.

People needed

98

Starts

2012-11-01

Expected to finish

2021-03-01

Last updated by the study team

2019-05-14

Who can join

Age: 21 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Actively participating in the BAROSTIM HOPE4HF Study and currently implanted with the BAROSTIM NEO device with the device turned ON.
• Have signed a revised approved informed consent form for continued participation in this study.

You may not qualify if…

• Treating physician decision that the subject should not continue with therapy.

Where it is running

• Southwest Cardiovascular Associates — Mesa, Arizona, United States
• Arizona Heart Rhythm Research Center — Phoenix, Arizona, United States
• University of Southern California — Los Angeles, California, United States
• George Washington University — Washington D.C., District of Columbia, United States
• ACRC - Cardiology — Atlantis, Florida, United States
• AdventHealth Orlando — Orlando, Florida, United States
• Tampa General Hospital — Tampa, Florida, United States
• Piedmont Heart Institute — Atlanta, Georgia, United States
• Advocate Medical Group — Naperville, Illinois, United States
• Cardiovascular Institute of the South — Houma, Louisiana, United States
• St Elizabeth's Medical Center — Brighton, Massachusetts, United States
• Mid-Michigan Medical Center Midland — Midland, Michigan, United States
• Cardiac & Vascular Research Center of Northern Michigan — Petoskey, Michigan, United States
• University of Mississippi Medical Center — Jackson, Mississippi, United States
• University Medical Center of Southern Nevada — Las Vegas, Nevada, United States
• Hackensack University Medical Center — Hackensack, New Jersey, United States
• The Ohio State University — Columbus, Ohio, United States
• Oklahoma Cardiovascular Research Group — Oklahoma City, Oklahoma, United States
• Drexel University College of Medicine — Philadelphia, Pennsylvania, United States
• Allegheny General Hospital — Pittsburgh, Pennsylvania, United States
• Lonestar Heart Center — Amarillo, Texas, United States
• Wheaton Franciscan Healthcare — Milwaukee, Wisconsin, United States
• Aspirus Heart & Vascular Institute — Wausau, Wisconsin, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.